Endonovo Therapeutics Inc (ENDV): FAKE NEWS!!! These guys are pathetic....

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Endonovo Therapeutics Inc (ENDV)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	19
Posts	1611
Boards Moderated	0
Alias Born	03/21/2017

Re: chrislal post# 30223

Monday, 12/03/2018 10:45:55 AM

Monday, December 03, 2018 10:45:55 AM

FAKE NEWS!!!

These guys are pathetic. They are using the exact same tactics they used when they announced the increase in A/S to 2.5 billion.

Announcing a non-binding letter of intent is the epitome of fake news and every $hitty penny stock has done it including ENDV.

This is a pathetic attempt to soften the blow from the news that really matters: what happened to the note? Obviously something happened but why not just come out and state it? Smells like ENDV has sold the US rights to SofPulse in exchange for paying off the note and now they are putting out these fake PRs to pump up the stock and soften the blow.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ENDV News

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/02/2024 10:23:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:30:14 PM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 12/29/2023 08:20:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:08:41 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 05:21:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 10:03:32 AM
Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 08/25/2023 11:04:33 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:16:04 PM

More ENDV News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow